Readout:

- Absorbance 

- Fluorescence 

- Luminescence 

  


Specifications:

- DxP6

- 8 parameters

  


  • In vitro assay development in the area of immunology/in vitro pharmacology
  • Therapeutic areas: cancer, autoimmunity, inflammation, orphan diseases
  • ​Biomarker assays

STRATEGIC/ PROJECT MANAGEMENT CAPABILITIES

ELISA    

  • Protein-based assays
  • Biological activity assays
  • Immunogenicity assays
  • Screening assays
  • Neutralizing antibody assays
  • ​PK/PD assays
  • ​Complement assays​​

FLOW CYTOMETRY

  • Cell sorting
  • Immunophenotyping
  • Intracellular staining
  • Drug binding
  • Efficacy assays
  • Competitive inhibition
  • Receptor occupancy
  • Apoptosis
  • ​Cell cycle
  • ​Multiplex cytokine detection


BENEFITS TO OUR CUSTOMERS

SERVICES

RESEARCH INSTITUTIONS THROUGH TECHNOLOGY TRANSFER OFFICES

  • Increasing the success rate of licensing of newly discovered molecules
  • ​Strengthening the university’s IP ​position​


INVESTORS (VC FIRMS, ANGELS)

  • Reducing risk associated with transfer of drug candidates from academia to industry
  • Providing fast and efficient solutions addressing reproducibility of academic data


BIOPHARMACEUTICAL COMPANIES

  • Significantly increasing the robustness, repeatability and reproducibility of transferred data and information
  • ​Providing a solid basis for initial drug development efforts
  • ​Accelerating the development process

OPERATIONAL IN-HOUSE CAPABILITIES

CELL CULTURE

  • Cell-based assays   


WESTERN BLOT​​  


ASSAY DEVELOPMENT AREAS

  • Reviewing academic documents an identifying gaps in program
  • ​Generating a project proposal for a development path of a drug candidate
  • Performing the assays according to industry standards 
  • Preparing a report containing all protocols and data suitable for licensing/funding
  • ​Designing and organizing initial R&D operations in immunology/in vitro pharmacology at ATR at client's site